FDA Warning Can't Bar Fresenius Dialysis Suits, Court Told

By Dani Kass (February 10, 2016, 2:11 PM EST) -- Hundreds of Massachusetts and Mississippi cases are eligible to join multidistrict litigation against Fresenius over GranuFlo's and NaturaLyte's alleged side effects, because there was no proof patients or their physicians knew about a 2012 FDA warning about the dialysis drugs, a court was told Wednesday....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!